DWP-820S002

N/A

Report date: 2022/02/23 14:15:19

Base Information

Drug NameDWP-820S002
Drug Alias NameDWP-820S002
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A